Kepos Capital LP Buys New Shares in Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACCU)

Kepos Capital LP bought a new stake in Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACCU) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 70,000 shares of the company’s stock, valued at approximately $709,000. Oaktree Acquisition Corp. III Life Sciences accounts for about 0.7% of Kepos Capital LP’s portfolio, making the stock its 12th largest position.

Oaktree Acquisition Corp. III Life Sciences Stock Performance

NASDAQ OACCU opened at $10.24 on Friday. The firm has a fifty day moving average price of $10.18. Oaktree Acquisition Corp. III Life Sciences has a 1 year low of $9.99 and a 1 year high of $10.50.

Oaktree Acquisition Corp. III Life Sciences Company Profile

We are a newly organized blank check company incorporated on June 28, 2024, as a Cayman Islands exempted company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this prospectus as our initial business combination.